|  |
FEATURED SCIENTISTS
Jean-Marie Bruey, Ph.D.; Burnham Institute, San Diego, CA
 In 2002, the Leukemia Research Foundation granted Jean-Marie Bruey, Ph.D., a two-year postdoctoral fellowship award for his project titled "NAC Expression and Function in Leukemia". Dr. Bruey completed his Ph.D. studies at the University of Dijon, in his native country, France. Upon graduation, he relocated to California where he is conducting a post-doctoral fellowship at The Burnham Institute under the supervision of Dr. John C Reed.
Very exciting work is going on in his laboratory. They have discovered the gene NAC, which promotes cell death. The research team is hoping to enhance the function of the gene and be able to encourage leukemia and lymphoma cells to die. In addition, better understanding of this gene may also lead to better treatment for leukemia and lymphoma patients.
Click HERE to read about Dr. Bruey's background as a researcher.
Andrea Cerutti, MD; Weil Medical College, Cornell University, New York, NY
 For the 2001-2002 funding cycle, Andrea Cerutti, MD received a New Investigator Award from the Leukemia Research Foundation for his project titled "Role of CD30-CD30L Interaction in Leukemia-associated Immunodeficiency and Malignant B Cell Clonal Expansion".
Click HERE to see a biography of Dr. Cerutti, and a brief description of his project.
Barbara Kee, PhD; The University of Chicago, Chicago, IL
 In 2002-2003 the Leukemia Research Foundation granted Barbara Kee, Ph.D. a $75,000 New Investigator award for a project she has recently completed. Born in London, Ontario, Canada Dr. Kee completed her undergraduate and graduate studies at the University of Toronto. Subsequent to graduation she relocated to California where she did a post-doctoral fellowship at the University of California at San Diego. In September of 2001 Dr. Kee started her own lab at the University of Chicago in the Department of Pathology. She is currently a member of the University of Chicago Cancer Center, and the Committees on Immunology, Cancer Biology, and Developmental Biology. In 2003 she was named the Raymond F. Zelko Young Investigator of the Cancer Research Foundation.
Even in childhood Dr. Kee felt a strong interest in the physical sciences, but it was not until she entered college that she seriously considered a career in biology. Once she took her first Molecular Biology and Immunology class she became fascinated with the possible knowledge and medical benefits that could be gained in this area. Below she describes her most recent project which the Foundation funded, titled Analysis of the Mechanism of E2A-Mediated Suppression of T-Cell Lymphoma.
Click here to download Dr. Kee's summary of her research project in PDF format.
Click here to see a copy of Dr. Kee's CV
|
|
|
